5-oxo-2-[4-(4,5,6,7-tetrahydrobenzoxazol-2-yl)-piperidin-1-yl]-6,7-dihydro-5h-5|4-thieno[3,2-d]pyrimidin-4-yl}-(tetrahydropyran-4-yl)-amine and a pharmaceutical composition comprising thereof.

Abstract

The invention relates to new piperidino-dihydrothienopyrimidines of formula 1, wherein X is SO or SO2, but preferably SO, and wherein R1 , R2 , R3 and R4 may have the meanings given in claim 1, as well as pharmaceutical compositions which contain these compounds. These new piperidino-dihydrothienopyrimidines are suitable for the treatment of respiratory or gastrointestinal complaints or diseases, inflammatory diseases of the joints, skin or eyes, diseases of the peripheral or central nervous system or cancers.